-
-
Call more information
660-596-2224 -
Authors: Vellinga, Remco M.D.et al Anesthesiology January 15, 2025. Background: Synergistic effects between opioids and remimazolam on bispectral index (BIS) and modified observer’s assessment of alertness and/or sedation (MOAAS) score were previously described. This study aimed to characterize the influence of remifentanil on the sedative properties of remimazolam as measured by MOAAS, BIS, tolerance to […]
Read MoreAuthor: Laura Dyrda Becker’s ASC Review There are 6,300 Medicare-certified ASCs in the U.S., a 3.5% increase over December 2022, according to CMS data. ASCA reported the number of ASCs by state as of September 2024. Some states have grown their ASC count significantly over the last two years while others reported declines. California has the most […]
Read MoreAuthor: Sundararaman, Lalitha MBBS, MD, FASA ASA Monitor 89(1):p 10, January 2025. IBUPROFEN AND POSTOP DELIRIUM Abstract Depending on the surgical procedure performed, the incidence of postoperative delirium is a staggering 15%-50% (Central Nervous System Risk Assessment: Preventing Postoperative Brain Injury. 2, 2022). Hence, any drug that can be administered to decrease this risk would be […]
Read MoreAuthors: Spence, Jessica MD, PhD et al Anesthesiology January 09, 2025. Background: Delirium is an acute state of confusion associated with adverse postoperative outcomes. Delirium is diagnosed clinically using screening tools; most cases go undetected. Identifying a delirium biomarker would allow for accurate diagnosis, application of therapies, and insight into causal pathways. To agnostically discover […]
Read MoreIf you’re an anesthesiologist searching for a balanced lifestyle and rewarding work, you’ll want to check out this opportunity. Our all-anesthesiologist group is seeking a dedicated team member to join our collaborative practice. Position Highlights: Zero Call for 3 Weeks: Enjoy three weeks of no call duty, followed by one week of call. Even during […]
Read More